resebidrag France
Reference number | |
Coordinator | DOUBLE BOND PHARMACEUTICALS AB - Double Bond Pharmaceutical AB |
Funding from Vinnova | SEK 10 000 |
Project duration | November 2017 - January 2018 |
Status | Completed |
Venture | Travel grant |
Call | Travel grant for building international consortia |
Important results from the project
Information about Double Bond Pharmaceutical and products Temodex SA033 was presented for potential partners (Ipsen and Servier) as well as VC companies (like for example Industriefonden)
Expected long term effects
The meetings were in accordance to the plan
Approach and implementation
The meetings were in accordance to the plan